BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Shield Therapeutics U.S. Composition Of Matter Patent

  September 6, 2017

   · 

  3 min read
• Drug Development

  Sarepta Announces Positive Results In Its Study Evaluating Gene Expression, Dystrophin Production, And Dystrophin Localization In Patients With Duchenne Muscular Dystrophy (DMD) Amenable To Skipping Exon 53 Treated With Golodirsen (SRP-4053)

  September 6, 2017

   · 

  9 min read
• Business

  Akcea Therapeutics Establishes Canadian Subsidiary

  September 6, 2017

   · 

  6 min read
• Drug Development

  Aeglea Doses Two Patients In Repeat Dose Part Of Phase I/II Clinical Trial For The Treatment Of Arginase 1 Deficiency

  September 6, 2017

   · 

  4 min read
• Business

  Congenica’s Sapientia Selected By Coimbra Paediatric Hospital For Portugal’s In2genome Genetic Disease Diagnosis Project

  September 6, 2017

   · 

  5 min read
• Business

  T2 Biosystems Announces Collaboration With CDC To Detect Emerging Superbug Candida Auris

  September 6, 2017

   · 

  7 min read
• Ingenza Invests In Faster Fermentation Development

  September 6, 2017

   · 

  2 min read
• Policy

  ContraVir Announces Acceptance Of Clinical Trial Application In The United Kingdom

  September 6, 2017

   · 

  4 min read
• Business

  BioNTech Enters Into Licensing Agreement With Cellscript, LLC As It Advances Development Of Messenger Rna Encoding Bispecific Antibodies And Other Therapeutic Proteins

  September 6, 2017

   · 

  3 min read
• Helsinn Announces Upcoming Presentation Of Phase III Data Of Nepa (Fosnetupitant/ Palonosetron) Iv At ESMO 2017

  September 6, 2017

   · 

  7 min read